IDEXX Laboratories, Inc.
IDXX
$430.12
$1.090.25%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 11.12% | 9.71% | -9.34% | 10.06% | 12.96% |
| Total Depreciation and Amortization | 13.35% | 17.76% | 15.57% | 5.55% | 3.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 228.80% | -30.91% | -118.43% | 19.63% | -198.76% |
| Change in Net Operating Assets | -120.89% | -457.25% | 123.92% | -15.31% | 195.20% |
| Cash from Operations | 4.87% | -19.22% | 23.96% | 7.98% | 44.07% |
| Capital Expenditure | 10.14% | 17.61% | -21.24% | 23.38% | 33.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -599.20% | -93.37% | -- | -- | -- |
| Cash from Investing | -30.91% | 1.69% | -19.79% | -170.67% | 38.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -513.75% | -- | -- | -- |
| Issuance of Common Stock | 16.99% | -60.41% | -47.89% | 63.17% | -9.29% |
| Repurchase of Common Stock | -566.44% | -525.97% | -272,811.39% | -1,618.80% | 50.16% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -10.56% |
| Cash from Financing | -128.57% | -576.10% | -39.20% | 1.37% | 12.75% |
| Foreign Exchange rate Adjustments | -309.48% | 296.89% | -197.06% | -911.58% | -20.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -116.66% | -146.74% | -80.64% | -4,692.11% | 814.26% |
